Alpha DNA Investment Management’s Albertsons Companies ACI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-39,016
Closed -$1.04M – 148
2022
Q2
$1.04M Sell
39,016
-5,339
-12% -$163K 0.89% 40
2022
Q1
$1.47M Sell
44,355
-7,435
-14% -$231K 1.04% 10
2021
Q4
$1.56M Buy
+51,790
New +$1.64M 0.99% 51
2021
Q2
– Sell
-37,213
Closed -$708K – 106
2021
Q1
$708K Sell
37,213
-13,049
-26% -$229K 0.81% 33
2020
Q4
$883K Buy
+50,262
New +$762K 0.94% 29

Other funds holding ACI

Alpha DNA Investment Management's ACI Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of Albertsons Companies (ACI) in Q3 2022, closing a stake of 39,016 shares — an estimated $1.04M sold.

Alpha DNA Investment Management first reported a position in ACI in Q4 2020 and held it in 5 quarters. The position peaked at $1.56M in Q4 2021. 310 funds tracked by Wall St. Rank hold ACI as of Q3 2022.

  • Alpha DNA Investment Management reported no remaining Albertsons Companies position as of Q3 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 39,016 Albertsons Companies shares in Q3 2022, an estimated $1.04M.
  • Alpha DNA Investment Management first reported a position in Albertsons Companies in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's Albertsons Companies position peaked at $1.56M in Q4 2021.
  • 310 funds tracked by Wall St. Rank held Albertsons Companies as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.